Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-aminomethyl-1-(5,7-difluoro-1,2,3,4-tetrahydronaphth-2-yl)-1,3-dihydroimidazole-2-thione
2. Rs 25560-197
3. Rs-25560-197
1. 173997-05-2
2. Syn117
3. Nepicastat [inn]
4. Syn-117
5. 4-(aminomethyl)-3-[(2s)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-1h-imidazole-2-thione
6. Vpg12k4540
7. 5-(aminomethyl)-1-((s)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthyl)-4-imidazoline-2-thione
8. (s)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1h-imidazole-2(3h)-thione
9. Rs-25560-197
10. (s)-5-aminomethyl-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1,3-dihydroimidazole-2-thione
11. (s)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1h-imidazole-2(3h)-thione
12. 2h-imidazole-2-thione, 5-(aminomethyl)-1-[(2s)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-
13. Nepicastatum
14. Unii-vpg12k4540
15. Schembl662220
16. Gtpl6630
17. Chembl1188395
18. Dtxsid80169740
19. Chebi:139334
20. Bcp05303
21. Zinc3936852
22. Akos016001464
23. Bcp9000983
24. Cs-0515
25. Db12979
26. Ncgc00346651-01
27. Ncgc00346651-09
28. (s)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1,3-dihydro-2h-imidazole-2-thione
29. Ac-27759
30. Hy-13289
31. Rs-25560
32. Syn117;rs-25560-197
33. Q6593941
34. (s)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)-1,3-dihydro-2h-imidazole-2-thione
35. 2h-imidazole-2-thione,5-(aminomethyl)-1- (5,7-difluoro-1,2,3,4-tetrahydro-2- Naphthalenyl)-1,3-dihydro-,(s)-
36. 2h-imidazole-2-thione,5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)-1,3-dihydro-,(s)-
37. 5-(aminomethyl)-1-[(2s)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-1,3-dihydro-2h-imidazole-2-thione
38. 5-(aminomethyl)-1-[(2s)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-3h-imidazole-2-thione
Molecular Weight | 295.35 g/mol |
---|---|
Molecular Formula | C14H15F2N3S |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 295.09547499 g/mol |
Monoisotopic Mass | 295.09547499 g/mol |
Topological Polar Surface Area | 73.4 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 429 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
47
PharmaCompass offers a list of Nepicastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nepicastat manufacturer or Nepicastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nepicastat manufacturer or Nepicastat supplier.
PharmaCompass also assists you with knowing the Nepicastat API Price utilized in the formulation of products. Nepicastat API Price is not always fixed or binding as the Nepicastat Price is obtained through a variety of data sources. The Nepicastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nepicastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nepicastat, including repackagers and relabelers. The FDA regulates Nepicastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nepicastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nepicastat supplier is an individual or a company that provides Nepicastat active pharmaceutical ingredient (API) or Nepicastat finished formulations upon request. The Nepicastat suppliers may include Nepicastat API manufacturers, exporters, distributors and traders.
Nepicastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nepicastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nepicastat GMP manufacturer or Nepicastat GMP API supplier for your needs.
A Nepicastat CoA (Certificate of Analysis) is a formal document that attests to Nepicastat's compliance with Nepicastat specifications and serves as a tool for batch-level quality control.
Nepicastat CoA mostly includes findings from lab analyses of a specific batch. For each Nepicastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nepicastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Nepicastat EP), Nepicastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nepicastat USP).